Загрузка...

Pharmacokinetics of Zanamivir following Intravenous Administration to Subjects with and without Renal Impairment

Intravenous zanamivir is in clinical development for the treatment of influenza in hospitalized patients, many of whom have renal impairment. This open-label study evaluated zanamivir pharmacokinetics and clinical safety following a single 100-mg intravenous infusion dose in subjects with impaired r...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Weller, Stephen, Jones, Lori S., Lou, Yu, Peppercorn, Amanda, Ng-Cashin, Judith
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2013
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3697365/
https://ncbi.nlm.nih.gov/pubmed/23587959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02330-12
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!